Guerbet Vendor's profile
A pioneer in the field of contrast agents with more than 80 years of experience
A pioneer in the field of contrast agents with more than 80 years of experience, Guerbet is the only pharmaceutical group fully dedicated to medical imaging worldwide. As such it has a complete offering of contrast agents for X-ray, MRI and interventional radiology, along with a range of injectors and related medical devices to provide improved patient diagnosis and treatment.
To promote the discovery of new products and ensure its future growth, Guerbet devotes significant resources to research and development every year (approximately 10% of sales, over 200 employees). Guerbet (GBT) is listed on NYSE Euronext Paris (Eurolist Compartment B – Mid Caps) and had sales of €390 million in 2013 with a total workforce of 1,485 employees.
Follow Guerbet on the web and social networks:
To feature here : Get in touch
Pourquoi avoir une gestion en temps en réel de la dose d'irradiation des patients ?
Ziehm Vision RFD Hybrid Edition: Mobility and flexibility – the difference in an emergency
Olea Medical® literature meta-analysis on CTP thresholds in acute stroke
Olea Medical® case report on early & late MR diffusion follow-up of a stroke using CT perfusion.
Agfa HealthCare Special Report Dose Management: because life is precious.